 Home > Active Ingredient News > Study of Nervous System > Du Yifeng, Wang Lihua, Cao Yongjun Interview: Vascular re-communication "joins hands" with TK supplementary treatment to improve the efficacy of AIS treatment and achieve a better prognosis for patients!

Du Yifeng, Wang Lihua, Cao Yongjun Interview: Vascular re-communication "joins hands" with TK supplementary treatment to improve the efficacy of AIS treatment and achieve a better prognosis for patients!

 Last Update: 2022-09-14
 Source: Internet
 Author: User

Tags

immune system explained

what spironolactone used

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Stroke has surpassed cardiovascular disease and tumors, becoming the second leading cause

Professor Du Yifeng

Director of the Department of Neurology, Shandong First Medical University, doctoral supervisor
Director of the Department of Neurology, Shandong Provincial Hospital
Taishan Scholar Distinguished Expert
Chief Scientist of the National Key R&D Program
Vice President of neurologist branch of Chinese Medical Doctor Association
Deputy Leader of dementia and Cognitive Disorders Group of Neurology Branch of Chinese Medical Association
Director of Shandong Clinical Research Center for Nervous System Diseases
He is the deputy editor-in-chief of the Chinese Journal of Behavioral Medicine and Brain Science

Professor Wang Lihua

Director of the Department of Neurology, Director of the Stroke Center, and First-class Specialist Leader of the Second Affiliated Hospital of Harbin Medical University enjoy special allowances from the provincial government
Vice Chairman of the Chinese Stroke Specialist Alliance
Secretary General of the Management Steering Committee of the China Stroke Center, Leader of the Supervision Expert Group of the Brain Prevention Committee of the National Health Commission
He is a national member of the Neurology Branch of the Chinese Medical Association
He is the chairman of the Neurology Professional Committee of Heilongjiang Medical Association and the president of Heilongjiang Stroke Society
The editorial board of the Chinese Journal of Neurology and other more than 40 important social part-time jobs
Won the Academic Achievement Award of Outstanding Neurologists of the Chinese Medical Doctor Association; The National Health Commission Brain Defense Committee awarded the Outstanding Contribution Expert Award; In 2019, he won the Dean's Special Award; Approved as An Outstanding Professor of Harbin Medical University Star Federation; Outstanding scientific and technological workers in Heilongjiang Province; Ranked among the top 100 academic influence of neurology experts in China, the latest ranking is 65th

Professor Cao Yongjun

Chief physician, professor and doctoral supervisor of the Second Affiliated Hospital of Soochow University
Visiting Scholar at the George Institute for Health, Sydney, Australia
Outstanding young and middle-aged experts of the National Brain Defense Commission
Standing Director of cerebral small blood vessel disease branch of Chinese Stroke Society, member of cerebral blood flow and metabolism branch
Member of the Cerebrovascular Disease Committee of the Chinese Medical Doctor Association
Deputy Leader of cerebrovascular disease group of Jiangsu Neurology Branch
Vice Chairman of the Neurology Committee of Suzhou Medical Association and Leader of the Cerebrovascular Disease Group
Good at standardized diagnosis and treatment of cerebrovascular disease; He has presided over 4 national natural science foundations and published more than 200 papers, including more than 50 papers

Wang Lihua
professor

For stroke treatment, what we need to emphasize at present is the construction of an efficient stroke treatment system, so that each AIS patient can be found in time after the onset of the disease and receive timely treatment

Du Yifeng
professor

The most effective treatment for AIS is vascular recanalization early after the onset of the disease to rescue ischemic semi-dark bands and restore neurological function

Cao Yongjun
professor

First, TK is very closely related

Cao Yongjun
professor

As the most commonly used treatment for AIS vascular recantherapy, intravenous thrombolysis is not only limited by a strict time window, but also the risk of END after thrombolysis is also a problem that clinicians

Wang Lihua

professor

Stroke recurrence rates are higher, and recurrence is worse than the first prognosis, which seriously affects the patient's own quality of

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.